Buy Day today: Good (67) Broad market participation · no major macro event

Haemonetics Corporation (HAE)

Healthcare Medical Devices

86.80 $

+1.5% vs. previous close

Closing price · As of: 3. Aug 2026

Haemonetics Corporation (HAE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 346 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Income Statement HAE
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	LTM
Revenue	311	318	336	343	336	346	349	331	321	327	339	346	1,334
Cost of Revenue	144	148	151	154	157	154	149	149	130	144	148	148	569
Gross Profit	167	171	185	189	179	191	200	182	192	183	191	198	765
Research & Development	13	13	13	24	14	14	16	16	16	15	14	14	60
Selling, General & Administrative	93	105	112	108	108	107	106	115	111	102	107	121	440
Total Operating Expenses	114	135	139	159	140	140	141	130	138	116	122	147	523
Operating Income	54	35	46	30	40	52	59	51	54	67	70	51	242
Interest Expense	2.1	2.5	1.9	6.5	7.0	7.0	9.1	0.6	4.1	7.2	8.1	5.4	25
Pre-Tax Income	52	33	44	23	47	45	50	71	45	51	60	-28	128
Income Tax Expense	11	7.9	13	3.0	8.3	11	12	13	11	13	15	-8.3	31
Net Income	41	25	31	20	38	34	37	58	34	39	45	-20	97
EBITDA	77	66	83	68	80	89	95	99	94	87	95	4.3	280

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings